<html>
<head>PUBMED IDs for TRIAP1</head>
<body bgcolor='#C5F0F2'><h1>TRIAP1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/23684607/'>A genetic screen identifies TCF3/E2A and TRIAP1 as pathway-specific regulators of the cellular response to p53 activation.</a> December 18  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23684582/'>Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis.</a> September 14  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25004126/'>Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.</a> April 23  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/27241913/'>MICOS and phospholipid transfer by Ups2-Mdm35 organize membrane lipid synthesis in mitochondria.</a> May 30  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27428374/'>Overexpression of Mitochondria Mediator Gene TRIAP1 by miR-320b Loss Is Associated with Progression in Nasopharyngeal Carcinoma.</a> March 28  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28588697/'>MicroRNA-18a inhibits ovarian cancer growth via directly targeting TRIAP1 and IPMK.</a> June 8  2017<br></body></html>
